Molecular genetics of Crohn's disease

Current Opinion in Genetics and Development

Volumn 14, Issue 3, 2004, Pages 264-270

  Russell, Richard K ^a   Nimmo, Elaine R ^a   Satsangi, Jack ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

CARD; caspase activating recruitment domain; CD; Crohn's disease; genome wide scanning; GWS; IBD; IFN ; inflammatory bowel disease; interferon ; leucine rich region; lipopolysaccharide; LPS; LRR; MDP; muramyl dipeptide; NF B

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15;

CHROMOSOME ANALYSIS; CORRELATION ANALYSIS; CROHN DISEASE; DISEASE ASSOCIATION; DISEASE MODEL; DISEASE PREDISPOSITION; ENTERITIS; GENE; GENE CONSTRUCT; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GENE LOCUS; GENE MUTATION; GENE REPLICATION; GENE STRUCTURE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC MARKER; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC TRAIT; GENOME ANALYSIS; GENOTYPE; HUMAN; MOLECULAR GENETICS; NOD2 GENE; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PHENOTYPE; POPULATION GENETICS; POPULATION RESEARCH; PRIORITY JOURNAL; PROTEIN STRUCTURE; REVIEW; RISK ASSESSMENT; STRUCTURE ANALYSIS;

ANIMALS; CHROMOSOME MAPPING; CROHN DISEASE; DISEASE MODELS, ANIMAL; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENETICS, POPULATION; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LINKAGE (GENETICS); MICE; MOLECULAR BIOLOGY; NOD2 SIGNALING ADAPTOR PROTEIN;

EID: 2542484534     PISSN: 0959437X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gde.2004.04.004     Document Type: Review

References (53)

1. Rubin G.P., Hungin A.P., Kelly P.J., Ling J. Inflammatory bowel disease: epidemiology and management in an English general practice population. Aliment Pharmacol Ther. 14:2000;1553-1559
2. Cosnes J., Cattan S., Blain A., Beaugerie L., Carbonnel F., Parc R., Gendre J.P. Long-term evolution of disease behavior of Crohn's disease. Inflamm Bowel Dis. 8:2002;244-250
3. Bonen D.K., Cho J.H. The genetics of inflammatory bowel disease. Gastroenterology. 124:2003;521-536
4. Gasche C., Scholmerich J., Brynskov J., D'Haens G., Hanauer S.B., Irvine E.J., Jewell D.P., Rachmilewitz D., Sachar D.B., Sandborn W.J., Sutherland L.R. A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis. 6:2000;8-15
5. Arnott I.D., Satsangi J. Crohn's disease or Crohn's diseases? Gut. 52:2003;460-461
6. Lander E., Kruglyak L. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet. 11:1995;241-247
7. Hugot J.P., Laurent-Puig P., Gower-Rousseau C., Olson J.M., Lee J.C., Beaugerie L., Naom I., Dupas J.L., Van Gossum A., Orholm M., et al. Mapping of a susceptibility locus for Crohn's disease on chromosome 16. Nature. 379:1996;821-823
8. Cavanaugh J. IBD International Genetics Consortium: International collaboration provides convincing linkage replication in complex disease through analysis of a large pooled data set: Crohn disease and chromosome 16. Am J Hum Genet. 68:2001;1165-1171
9. Ogura Y., Bonen D.K., Inohara N., Nicolae D.L., Chen F.F., Ramos R., Britton H., Moran T., Karaliuskas R., Duerr R.H., et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature. 411:2001;603-606
10. Hugot J.P., Chamaillard M., Zouali H., Lesage S., Cezard J.P., Belaiche J., Almer S., Tysk C., O'Morain C.A., Gassull M., et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature. 411:2001;599-603
11. Shaw S.H., Hampe J., White R., Mathew C.G., Curran M.E., Schreiber S. Stratification by CARD15 variant genotype in a genome-wide search for inflammatory bowel disease susceptibility loci. Hum Genet. 113:2003;514-521
12. Lesage S., Zouali H., Cezard J.P., Colombel J.F., Belaiche J., Almer S., Tysk C., O'Morain C., Gassull M., Binder V., et al. CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet. 70:2002;845-857 A comprehensive study of NOD2/CARD15 mutations describing >60 sequence changes in the gene and identifying 27 rare disease-causing mutations as well as demonstrating phenotypic correlations with ileal and early-onset disease.
13. Inoue N., Tamura K., Kinouchi Y., Fukuda Y., Takahashi S., Ogura Y., Inohara N., Nunez G., Kishi Y., Koike Y., et al. Lack of common NOD2 variants in Japanese patients with Crohn's disease. Gastroenterology. 123:2002;86-91
14. Sun L.R., Roesler J., Rösen-Wolff A., Winkler U., Koch R., Thürigen A., Henker J. CARD15 Genotype and phenotype analysis in 55 pediatric patients with Crohn disease from Saxony, Germany. J Pediatr Gastroenterol Nutr. 37:2003;492-497
15. Sugimura K., Taylor K.D., Lin Y.C., Hang T., Wang D., Tang Y.M., Fischel-Ghodsian N., Targan S.R., Rotter J.I., Yang H. A novel NOD2/CARD15 haplotype conferring risk for Crohn disease in Ashkenazi Jews. Am J Hum Genet. 72:2003;509-518
16. Bairead E., Harmon D.L., Curtis A.M., Kelly Y., O'Leary C., Gardner M., Leahy D.T., Vaughan P., Keegan D., O'Morian C., et al. Association of NOD2 with Crohn's Disease in a homogenous Irish population. Eur J Hum Genet. 11:2003;237-244
17. Ahmad T., Armuzzi A., Bunce M., Mulcahy-Hawes K., Marshall S.E., Orchard T.R., Crawshaw J., Large O., de Silva A., Cook J.T., et al. The molecular classification of the clinical manifestations of Crohn's disease. Gastroenterology. 122:2002;854-866 A painstaking examination of a large cohort of rigorously phenotyped patients looking at the common NOD2/CARD15 mutations as well as 24 HLA genes. The authors describe association of NOD2/CARD15 mutations with ileal disease and show that HLA genes are involved in CD susceptibility and phenotype.
18. Cuthbert A.P., Fisher S.A., Mirza M.M., King K., Hampe J., Croucher P.J., Mascheretti S., Sanderson J., Forbes A., Mansfield J., et al. The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease. Gastroenterology. 122:2002;867-874
19. Hugot J.P.Z. Lessons to be learned from the NOD2 gene in Crohn's disease. Eur J Gastroenterol Hepatol. 15:2003;593-597
20. Inohara N., Ogura Y., Nunez G. Nods: a family of cytosolic proteins that regulate the host response to pathogens. Curr Opin Microbiol. 5:2002;76-80
21. Zouali H., Lesage S., Merlin F., Cezard J.P., Colombel J.F., Belaiche J., Almer S., Tysk C., O'Morain C., Gassull M., et al. CARD4/NOD1 is not involved in inflammatory bowel disease. Gut. 52:2003;71-74
22. Gutierrez O., Pipaon C., Inohara N., Fontalba A., Ogura Y., Prosper F., Nunez G., Fernandez-Luna J.L. Induction of Nod2 in myelomonocytic and intestinal epithelial cells via nuclear factor-kappa B activation. J Biol Chem. 277:2002;41701-41705
23. Rosenstiel P., Fantini M., Brautigam K., Kuhbacher T., Waetzig G.H., Seegert D., Schreiber S. TNF-alpha and IFN-gamma regulate the expression of the NOD2 (CARD15) gene in human intestinal epithelial cells. Gastroenterology. 124:2003;1001-1009
24. Lala S., Ogura Y., Osborne C., Hor S.Y., Bromfield A., Davies S., Ogunbiyi O., Nunez G., Keshav S. Crohn's disease and the NOD2 gene: a role for Paneth cells. Gastroenterology. 125:2003;47-57
25. Albrecht M., Domingues F.S., Schreiber S., Lengauer T. Structural localization of disease-associated sequence variations in the NACHT and LRR domains of PYPAF1 and NOD2. FEBS Lett. 554:2003;520-528
26. Ogura Y., Inohara N., Benito A., Chen F.F., Yamaoka S., Nunez G. Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-kappaB. J Biol Chem. 276:2001;4812-4818
27. Inohara N., Ogura Y., Fontalba A., Gutierrez O., Pons F., Crespo J., Fukase K., Inamura S., Kusumoto S., Hashimoto M., et al. Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease. J Biol Chem. 278:2003;5509-5512
28. Girardin S.E., Boneca I.G., Viala J., Chamaillard M., Labigne A., Thomas G., Philpott D.J., Sansonetti P.J. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J Biol Chem. 278:2003;8869-8872 The authors demonstrate that the specific moiety in bacteria that stimulates the NOD2/CARD15 pathway is muramyl dipeptide (MDP) present in peptidoglycan. The authors compared the ability of wild-type NOD2 and the 1007fs mutation to detect MDP showing enhanced NF-κB activity with wild type but absent response with possession of the 1007fs mutation. This suggests that CD results from an abnormal response to pathogens.
29. Kobayashi K., Inohara N., Hernandez L.D., Galan J.E., Nunez G., Janeway C.A., Medzhitov R., Flavell R.A. RICK/Rip2/CARDIAK mediates signalling for receptors of the innate and adaptive immune systems. Nature. 416:2002;194-199
30. Bonen D.K., Ogura Y., Nicolae D.L., Inohara N., Saab L., Tanabe T., Chen F.F., Foster S.J., Duerr R.H., Brant S.R., et al. Crohn's disease-associated NOD2 variants share a signaling defect in response to lipopolysaccharide and peptidoglycan. Gastroenterology. 124:2003;140-146
31. Hisamatsu T., Suzuki M., Reinecker H.C., Nadeau W.J., McCormick B.A., Podolsky D.K. CARD15/NOD2 functions as an antibacterial factor in human intestinal epithelial cells. Gastroenterology. 124:2003;993-1000 The authors demonstrated the expression of NOD2/CARD15 in intestinal epithelial cells. Using Caco2 cell lines, they demonstrated failure of clearance of salmonella typhinurium in NOD2/CARD15 mutant cells but not wild type.
32. Iwanaga Y., Davey M.P., Martin T.M., Planck S.R., DePriest M.L., Baugh M.M., Suing C.M., Rosenbaum J.T. Cloning, sequencing and expression analysis of the mouse NOD2/CARD15 gene. Inflamm Res. 52:2003;272-276
33. -/- mice show no intestinal pathology, have enhanced survival to endotoxic shock and show a lack of cytokine response to MDP stimulation. This model will allow testing of NOD2 response to specific intestinal pathogens.
34. Satsangi J., Parkes M., Louis E., Hashimoto L., Kato N., Welsh K., Terwilliger J.D., Lathrop G.M., Bell J.I., Jewell D.P. Two stage genome-wide search in inflammatory bowel disease provides evidence for susceptibility loci on chromosomes 3, 7 and 12. Nat Genet. 14:1996;199-202
35. Parkes M., Barmada M.M., Satsangi J., Weeks D.E., Jewell D.P., Duerr R.H. The IBD2 locus shows linkage heterogeneity between ulcerative colitis and Crohn disease. Am J Hum Genet. 67:2000;1605-1610
36. Williams C.N., Kocher K., Lander E.S., Daly M.J., Rioux J.D. Using a genome-wide scan and meta-analysis to identify a novel IBD locus and confirm previously identified IBD loci. Inflamm Bowel Dis. 8:2002;375-381
37. Rioux J.D., Silverberg M.S., Daly M.J., Steinhart A.H., McLeod R.S., Griffiths A.M., Green T., Brettin T.S., Stone V., Bull S.B., et al. Genomewide search in Canadian families with inflammatory bowel disease reveals two novel susceptibility loci. Am J Hum Genet. 66:2000;1863-1870
38. Ma Y., Ohmen J.D., Li Z., Bentley L.G., McElree C., Pressman S., Targan S.R., Fischel-Ghodsian N., Rotter J.I., Yang H. A genome-wide search identifies potential new susceptibility loci for Crohn's disease. Inflamm Bowel Dis. 5:1999;271-278
39. Hampe J., Schreiber S., Shaw S.H., Lau K.F., Bridger S., Macpherson A.J., Cardon L.R., Sakul H., Harris T.J., Buckler A., et al. A genomewide analysis provides evidence for novel linkages in inflammatory bowel disease in a large European cohort. Am J Hum Genet. 64:1999;808-816
40. Cho J.H., Nicolae D.L., Gold L.H., Fields C.T., LaBuda M.C., Rohal P.M., Pickles M.R., Qin L., Fu Y., Mann J.S., et al. Identification of novel susceptibility loci for inflammatory bowel disease on chromosomes 1p, 3q, and 4q: evidence for epistasis between 1p and IBD1. Proc Natl Acad Sci USA. 95:1998;7502-7507
41. Dechairo B., Dimon C., van Heel D., Mackay I., Edwards M., Scambler P., Jewell D., Cardon L., Lench N., Carey A. Replication and extension studies of inflammatory bowel disease susceptibility regions confirm linkage to chromosome 6p (IBD3). Eur J Hum Genet. 9:2001;627-633
42. Hampe J., Shaw S.H., Saiz R., Leysens N., Lantermann A., Mascheretti S., Lynch N.J., Macpherson A.J., Bridger S., van Deventer S., et al. Linkage of inflammatory bowel disease to human chromosome 6p. Am J Hum Genet. 65:1999;1647-1655
43. Fisher S.A., Hampe J., Macpherson A.J., Forbes A., Lennard-Jones J.E., Schreiber S., Curran M.E., Mathew C.G., Lewis C.M. Sex stratification of an inflammatory bowel disease genome search shows male-specific linkage to the HLA region of chromosome 6. Eur J Hum Genet. 10:2002;259-265
44. Stokkers P.C.F., Reitsma P.H., Tytgat G.N.J., van Deventer S.J.H. HLA-DR and -DQ phenotypes in inflammatory bowel disease: a meta-analysis. Gut. 45:1999;395-401
45. Duerr R.H., Barmada M.M., Zhang L., Pfutzer R., Weeks D.E. High-density genome scan in Crohn disease shows confirmed linkage to chromosome 14q11-12. Am J Hum Genet. 66:2000;1857-1862
46. Negoro K., McGovern D.P., Kinouchi Y., Takahashi S., Lench N.J., Shimosegawa T., Carey A., Cardon L.R., Jewell D.P., Van Heel D.A. Analysis of the IBD5 locus and potential gene-gene interactions in Crohn's disease. Gut. 52:2003;541-546
47. Mirza M.M., Fisher S.A., King K., Cuthbert A.P., Hampe J., Sanderson J., Mansfield J., Donaldson P., Macpherson A.J., Forbes A. Genetic evidence for interaction of the 5q31 cytokine locus and the CARD15 gene in Crohn disease. Am J Hum Genet. 72:2003;1018-1022
48. Cavanaugh J.A., Adams K.E., Quak E.J., Bryce M.E., O'Callaghan N.J., Rodgers H.J., Magarry G.R., Butler W.J., Eaden J.A., Roberts-Thomson I.C., et al. CARD15/NOD2 Risk alleles in the development of Crohn's disease in the Australian population. Ann Hum Genet. 67:2003;35-41
49. van Heel D.A., Udalova I.A., De Silva A.P., McGovern D.P., Kinouchi Y., Hull J., Lench N.J., Cardon L.R., Carey A.H., Jewell D.P., Kwiatkowski D. Inflammatory bowel disease is associated with a TNF polymorphism that affects an interaction between the OCT1 and NF(-kappa)B transcription factors. Hum Mol Genet. 11:2002;1281-1289
50. Vermeire S., Louis E., Rutgeerts P., De Vos M., Van Gossum A., Belaiche J., Pescatore P., Fiasse R., Pelckmans P., Vlietinck R., et al. NOD2/CARD15 does not influence response to infliximab in Crohn's disease. Gastroenterology. 123:2002;106-111
51. Mascheretti S., Hampe J., Croucher P.J., Nikolaus S., Andus T., Schubert S., Olson A., Bao W., Folsch U.R., Schreiber S. Response to infliximab treatment in Crohn's disease is not associated with mutations in the CARD15 (NOD2) gene: an analysis in 534 patients from two multicenter, prospective GCP-level trials. Pharmacogenetics. 12:2002;509-515
52. Barmada M.M., Brant S.R., Nicolae D.L., Achkar J.P., Panhuysen C.I., Bayless T.M., Cho J.H., Duerr R.H. A genome scan in 260 inflammatory bowel disease-affected relative pairs. Inflamm Bowel Dis. 10:2004;15-22
53. Vermeire S., Vlietinck R., Joossens S., Esters N., Peeters M., Rutgeerts P. Genome-wide scanning in a Belgian IBD population reveals novel linkages and validates previous linkages. Gastroenterology. 120:2001;2322